This PDF is the current document as it appeared on Public Inspection on 05/15/2014 at 08:45 am.
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following council meeting.
Times and Dates: 8:30 a.m.-5:00 p.m., June 9, 2014; 8:30 a.m.-2:30 p.m., June 10, 2014.
Place: CDC, Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, telephone (404) 639-8317. This meeting is also accessible by teleconference. Toll-free +1 (877) 927-1433, Participant code: 12016435.
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people.
Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis.
Matters for Discussion: Agenda items include the following topics: (1) U.S. Preventive Services Task Force/Assessing Evidence for treatment of Latent Tuberculosis Infection (LTBI) as prevention; (2) TB screening activities in Federally Qualified Health Centers (FQHCs); (3) Advanced Molecular Detection (AMD); (4) Updates from Workgroups; and (5) other tuberculosis-related issues. Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh, Centers for Disease Control and Prevention, 1600 Clifton Road NE., M/S E-07, Atlanta, Georgia 30333, telephone (404) 639-8317; Email: firstname.lastname@example.org.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Gary J. Johnson,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2014-11355 Filed 5-15-14; 8:45 am]
BILLING CODE 4163-18-P